Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $528.66 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $127.70 | 7 | $0 (2021) |
| Merck Sharp & Dohme LLC | $84.59 | 4 | $0 (2024) |
| RedHill Biopharma Inc. | $79.85 | 4 | $0 (2022) |
| Chiesi USA, Inc. | $51.01 | 3 | $0 (2024) |
| Braintree Laboratories, Inc. | $40.84 | 2 | $0 (2021) |
| Intercept Pharmaceuticals, Inc. | $24.11 | 1 | $0 (2021) |
| Olympus America Inc. | $21.91 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.20 | 1 | $0 (2020) |
| Ardelyx, Inc. | $20.30 | 1 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $20.07 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.05 | 7 | Merck Sharp & Dohme LLC ($84.59) |
| 2023 | $49.82 | 3 | Chiesi USA, Inc. ($29.75) |
| 2022 | $20.10 | 1 | RedHill Biopharma Inc. ($20.10) |
| 2021 | $157.81 | 8 | RedHill Biopharma Inc. ($59.75) |
| 2020 | $59.61 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21.20) |
| 2019 | $78.09 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($56.18) |
| 2017 | $18.18 | 1 | AbbVie, Inc. ($18.18) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/12/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/20/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/16/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/17/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Antibiotic | ||||||
| 12/15/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Antibiotic | ||||||
| 12/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 08/25/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Antibiotic | ||||||
| 07/07/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Gastroenterology | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Gastroenterology | ||||||
| 03/04/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Antibiotic | ||||||
| 01/19/2021 | Braintree Laboratories, Inc. | SUTAB (Drug), MOTOFEN, SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GI COLON PREP | ||||||
| 01/11/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 07/22/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/04/2020 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: GI COLON PREP | ||||||
| 01/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2019 | Olympus America Inc. | Olympus Tissue Acquisition Devices (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: EndoTherapy Products | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 226 | 231 | $354,826 | $31,588 |
| 2022 | 3 | 260 | 262 | $801,070 | $36,901 |
| 2021 | 3 | 294 | 297 | $998,920 | $42,122 |
| 2020 | 2 | 221 | 225 | $879,633 | $33,407 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2023 | 56 | 58 | $66,227 | $8,420 | 12.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 53 | 54 | $102,870 | $7,380 | 7.2% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 55 | 56 | $111,534 | $7,203 | 6.5% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2023 | 36 | 37 | $26,806 | $4,852 | 18.1% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 15 | 15 | $28,830 | $1,967 | 6.8% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 11 | 11 | $18,558 | $1,767 | 9.5% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2022 | 61 | 63 | $303,000 | $9,575 | 3.2% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 68 | 68 | $140,562 | $8,942 | 6.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 61 | 61 | $120,144 | $8,889 | 7.4% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2022 | 44 | 44 | $183,064 | $6,048 | 3.3% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 26 | 26 | $54,300 | $3,447 | 6.3% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 89 | 91 | $441,075 | $13,927 | 3.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 73 | 73 | $301,429 | $10,051 | 3.3% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 56 | 56 | $104,586 | $8,261 | 7.9% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 61 | 62 | $121,128 | $7,845 | 6.5% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 15 | 15 | $30,702 | $2,038 | 6.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 94 | 98 | $460,905 | $14,910 | 3.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 88 | 88 | $351,083 | $11,862 | 3.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 28 | 28 | $48,425 | $4,866 | 10.0% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 11 | 11 | $19,220 | $1,770 | 9.2% |
About Dr. Aziz Ibrahim, M.D
Dr. Aziz Ibrahim, M.D is a Anesthesiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437143831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aziz Ibrahim, M.D has received a total of $528.66 in payments from pharmaceutical and medical device companies, with $145.05 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($528.66).
As a Medicare-enrolled provider, Ibrahim has provided services to 1,001 Medicare beneficiaries, totaling 1,015 services with total Medicare billing of $144,019. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Brooklyn, NY
- Active Since 08/31/2005
- Last Updated 08/29/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437143831
Products in Payments
- XIFAXAN (Drug) $89.50
- Talicia (Drug) $79.85
- CLEVIPREX (Drug) $51.01
- DIFICID (Drug) $46.45
- TRULANCE (Drug) $38.20
- BRIDION (Drug) $38.14
- OCALIVA (Drug) $24.11
- SUTAB (Drug) $22.30
- Olympus Tissue Acquisition Devices (Device) $21.91
- SPIRIVA (Drug) $21.20
- IBSRELA (Drug) $20.30
- ZENPEP (Drug) $20.07
- VOQUEZNA (Drug) $18.90
- SUPREP BOWEL PREP (Drug) $18.54
- Creon (Drug) $18.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Brooklyn
Dr. Mark Kronenfeld, M.d, M.D
Anesthesiology — Payments: $2.5M
Mehrdad Hedayatnia, Md, MD
Anesthesiology — Payments: $27,710
Jason Kreiner, M.d, M.D
Anesthesiology — Payments: $19,382
Roman Shulkin, M.d, M.D
Anesthesiology — Payments: $15,731
Dr. Edwin Perez, M.d, M.D
Anesthesiology — Payments: $11,545
Shaesta Humayun, Md, MD
Anesthesiology — Payments: $7,219